Use of 7- (2-oxa-5,8-diazabicyclo [4.3.0] quinolone carboxylic acid and naphthydridoncarboxylsyrederivater for the manufacture of a medicament for the treatment of Helicobacter pylori infections and the gastroduodenal disorders associated therewith